The S&P/ASX 200 Index (ASX: XJO) has started the week positively. In afternoon trade, the benchmark index is up 0.3% to 6,998.1 points.
Four ASX shares that are rising more than most today are listed below. Here's why they are storming higher:
Imugene Limited (ASX: IMU)
The Imugene share price is up 6% to 5.1 cents. This morning, this clinical-stage immuno-oncology company reported positive early results from six patients with gastrointestinal cancers who received its novel cancer-killing virus CF33-hNIS. Management also revealed that all treatments to date have been determined safe and tolerable.
Mayne Pharma Group Ltd (ASX: MYX)
The Mayne Pharma share price is up 4% to $3.88. This has been driven by news that the pharmaceutical company has been granted a patent in the United States for its Nextstellis contraceptive. Management said: "This additional patent is meaningful as it provides the Company with an opportunity to extend women's access to this highly effective and unique oral contraceptive."
Westpac Banking Corp (ASX: WBC)
The Westpac share price is up 3% to $22.15. Investors have been buying the banking giant's shares after it released a FY 2023 result in line with expectations. In addition, the bank increased its dividend and announced a $1.5 billion on-market share buyback.
Wildcat Resources Ltd (ASX: WC8)
The Wildcat share price is up 11% to 92.5 cents. This morning, this lithium explorer released assay results from the Tabba Tabba Lithium Project in Western Australia. Management notes that the results support the "uncovering [of] a tier-1 lithium deposit at Tabba Tabba." This lithium project is in close proximity to the Pilbara Minerals Ltd (ASX: PLS) owned Pilgangoora Project and the Mineral Resources Ltd (ASX: MIN) owned Wodgina Project.